SCHEMBL8086642

SCHEMBL8086642

CCSN(SCC)C(=S)CCCCC(=S)N(SCC)SCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8086452 0.91 ALDH1A1 (0.35)
SCHEMBL1079287 0.90 PHGDH (0.31)
SCHEMBL7952884 0.79 PHGDH (0.31)
SCHEMBL1096599 0.77
SCHEMBL11229111 0.69 PHGDH (0.31)
SCHEMBL8816142 0.69 ALDH1A1 (0.48)
SCHEMBL11399453 0.69 PHGDH (0.31)
SCHEMBL5747742 0.69
SCHEMBL1079074 0.69
SCHEMBL11301441 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0725637-B1 PARENTERAL BUSULFAN FOR TREATMENT OF MALIGNANT DISEASE UNIV TEXAS (US) 2000-11-22 EP disclosed
US-5559148-A Parenteral busulfan for treatment of malignant disease BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1996-09-24 US disclosed
US-5430057-A Aqueous mixture with solvent; anticarcinogenic agents; leukemia, lymphoma BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1995-07-04 US disclosed